Plato Investment Management LTD Janux Therapeutics, Inc. Transaction History
Plato Investment Management LTD
- $1.36 Trillion
- Q4 2024
A detailed history of Plato Investment Management LTD transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 498 shares of JANX stock, worth $14,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
498
Previous 1,186
58.01%
Holding current value
$14,944
Previous $53.8 Million
50.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JANX
# of Institutions
228Shares Held
54.7MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$311 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$107 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$106 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$91.9 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$70.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.25B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...